These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 19860106)

  • 1. One year efficacy and safety of oral sildenafil treatment in severe pulmonary hypertension.
    Samarzija M; Zuljević E; Jakopović M; Sever B; Knezević A; Dumija Z; Vidjak V; Samija M
    Coll Antropol; 2009 Sep; 33(3):799-803. PubMed ID: 19860106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sildenafil therapy in secondary pulmonary hypertension: Is there benefit in prolonged use?
    Chapman TH; Wilde M; Sheth A; Madden BP
    Vascul Pharmacol; 2009; 51(2-3):90-5. PubMed ID: 19386283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy of oral sildenafil as rescue therapy in patients with severe pulmonary arterial hypertension chronically treated with prostacyclin. Long-term results].
    Jiménez López-Guarch C; Escribano Subias P; Tello de Meneses R; Delgado Jiménez JF; Sadia Pérez D; Velázquez Martín MT; Gómez Sánchez MA; Sáenz de la Calzada C
    Rev Esp Cardiol; 2004 Oct; 57(10):946-51. PubMed ID: 15469792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of transition from subcutaneous treprostinil to oral sildenafil in patients with pulmonary arterial hypertension.
    Keogh AM; Jabbour A; Weintraub R; Brown K; Hayward CS; Macdonald PS
    J Heart Lung Transplant; 2007 Nov; 26(11):1079-83. PubMed ID: 18022071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of oral sildenafil in severe pulmonary arterial hypertension: clinical efficacy and dose response relationship.
    Garg N; Sharma MK; Sinha N
    Int J Cardiol; 2007 Sep; 120(3):306-13. PubMed ID: 17174417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension.
    Michelakis ED; Tymchak W; Noga M; Webster L; Wu XC; Lien D; Wang SH; Modry D; Archer SL
    Circulation; 2003 Oct; 108(17):2066-9. PubMed ID: 14568893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does Sildenafil produce a sustained benefit in patients with pulmonary hypertension associated with parenchymal lung and cardiac disease?
    Madden BP; Sheth A; Wilde M; Ong YE
    Vascul Pharmacol; 2007; 47(2-3):184-8. PubMed ID: 17627899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy and tolerability of sildenafil in patients with moderate-to-severe pulmonary hypertension.
    Bharani A; Mathew V; Sahu A; Lunia B
    Indian Heart J; 2003; 55(1):55-9. PubMed ID: 12760589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy and safety of sildenafil in Chinese patients with pulmonary arterial hypertension.
    Xu XQ; Jing ZC; Zhang JH; Wu Y; Wang Y; Jiang X; Wang ZX; Sun YG; Pu JL; Yang YJ
    Hypertens Res; 2009 Oct; 32(10):911-5. PubMed ID: 19644505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, placebo-controlled, double-blind, crossover study to evaluate the efficacy of oral sildenafil therapy in severe pulmonary artery hypertension.
    Singh TP; Rohit M; Grover A; Malhotra S; Vijayvergiya R
    Am Heart J; 2006 Apr; 151(4):851.e1-5. PubMed ID: 16569546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension.
    Lewis GD; Shah R; Shahzad K; Camuso JM; Pappagianopoulos PP; Hung J; Tawakol A; Gerszten RE; Systrom DM; Bloch KD; Semigran MJ
    Circulation; 2007 Oct; 116(14):1555-62. PubMed ID: 17785618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic oral sildenafil therapy in severe pulmonary artery hypertension.
    Kothari SS; Duggal B
    Indian Heart J; 2002; 54(4):404-9. PubMed ID: 12462669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preliminary study on the efficacy and safety of oral sildenafil in pulmonary arterial hypertension in China].
    Xiong CM; He JG; Lu XL; Shan GL; Wu BX; Zhu XY; Wu GH; Zeng XF; Guo T; Liu ZH; Ni XH; Cheng XS; Gu Q; Zhao ZH; Tian HY; Li WM; Zhang DZ; Zhang C; Li MT; Liu HM; Guo YJ; Shen JY; Zhang WJ; Liu S; Zhou DX; Bao CD; Huang SA; Chen JY; Wu WF; Huang K; Li CL; Wang LH; He B
    Zhonghua Yi Xue Za Zhi; 2011 Feb; 91(6):370-4. PubMed ID: 21418907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sildenafil citrate therapy for pulmonary arterial hypertension.
    Galiè N; Ghofrani HA; Torbicki A; Barst RJ; Rubin LJ; Badesch D; Fleming T; Parpia T; Burgess G; Branzi A; Grimminger F; Kurzyna M; Simonneau G;
    N Engl J Med; 2005 Nov; 353(20):2148-57. PubMed ID: 16291984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sildenafil therapy for pulmonary arterial hypertension associated with atrial septal defects.
    Lim ZS; Salmon AP; Vettukattil JJ; Veldtman GR
    Int J Cardiol; 2007 May; 118(2):178-82. PubMed ID: 17027100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sildenafil therapy for pulmonary hypertension: a prospective study].
    Lu XL; Xiong CM; Shan GL; Liu ZH; Ni XH; Cheng XS; Gu Q; Zhao ZH; Zeng WJ; Zhu F; He JG
    Zhonghua Jie He He Hu Xi Za Zhi; 2011 Jun; 34(6):419-23. PubMed ID: 21781512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of chronic sildenafil in patients with Eisenmenger syndrome versus idiopathic pulmonary arterial hypertension.
    Chau EM; Fan KY; Chow WH
    Int J Cardiol; 2007 Sep; 120(3):301-5. PubMed ID: 17174418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of sildenafil as a rescue therapy for patients with severe pulmonary arterial hypertension and given long-term treatment with prostanoids: 2-year experience.
    Ruiz MJ; Escribano P; Delgado JF; Jiménez C; Tello R; Gómez MA; de la Calzada CS
    J Heart Lung Transplant; 2006 Nov; 25(11):1353-7. PubMed ID: 17097500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A potential role for sildenafil in the management of pulmonary hypertension in patients with parenchymal lung disease.
    Madden BP; Allenby M; Loke TK; Sheth A
    Vascul Pharmacol; 2006 May; 44(5):372-6. PubMed ID: 16574495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and haemodynamic effects of sildenafil in pulmonary hypertension: acute and mid-term effects.
    Mikhail GW; Prasad SK; Li W; Rogers P; Chester AH; Bayne S; Stephens D; Khan M; Gibbs JS; Evans TW; Mitchell A; Yacoub MH; Gatzoulis MA
    Eur Heart J; 2004 Mar; 25(5):431-6. PubMed ID: 15033256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.